Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Home/Opportunities/OPPORTUNITY: African Innovators can leverage Europe’s €12 Million Biotech Fund

OPPORTUNITY: African Innovators can leverage Europe’s €12 Million Biotech Fund

The European Commission has officially opened applications for a massive €12 million (approximately R240 million) Horizon Europe funding call, presenting a rare and lucrative opportunity for African scientists, agritech start-ups, and industrial innovators to co-develop next-generation biotechnology solutions.

Operating under the banner of Horizon Europe Cluster 6 (Food, Bioeconomy, Natural Resources, Agriculture and Environment), the grant focuses heavily on sustainability, circular economy deployment, and industrial competitiveness. For African innovators, this call is not just a source of capital – it is a strategic bridge to international research networks, advanced bio-foundries, and global markets.

The African Advantage: Why local Innovators are crucial partners

While the fund is European-driven, the guidelines explicitly encourage the participation of African organisations as core consortium partners. This inclusion recognizes that Africa is currently a hotbed for nature-based solutions, climate resilience frameworks, and biodiverse ecosystem restoration—the exact focus areas of this fund.

Furthermore, because the fund offers a 100% funding rate, African universities, science councils, and small-to-medium enterprises (SMEs) can participate in cutting-edge global research without the burden of co-financing, lowering the financial barrier to entry for local breakthroughs.

Target Areas: Where Africa can lead

The call excludes health biotechnology, biofuels, and bioenergy, focusing instead on industrial and ecological biotechnology. This aligns perfectly with Africa’s urgent trade and industrial needs, particularly in agricultural efficiency and waste reduction. Key eligible areas of interest include:

  • Advanced Engineering: Synthetic biology, metabolic engineering, and gene-editing technologies.
  • The Digital Frontier: AI, machine learning for biotechnology, and advanced bioinformatics applications.
  • Circular and Nature-Based Solutions: Biofoundries, microbiome innovation, resource efficiency, and waste reduction systems that can turn agricultural by-products into high-value tradable goods.

For an African agritech start-up working on microbiome innovations to boost crop climate-resilience, or a South African tech firm applying machine learning to biodiversity data, this grant offers the financial runway to scale concepts from the lab to industrial application.

The Power of Consortium: Building transnational Trade and Tech Links

To secure a slice of the €12 million pool – with individual projects expected to net roughly €4 million each – African entities must collaborate. The application requires an international consortium of at least three independent organisations from three different eligible countries, including at least one from an EU Member State.

Dozens of African nations are fully eligible to participate as partners, including regional economic drivers such as South Africa, Kenya, Nigeria, Ghana, Rwanda, and members of the Southern African Development Community (SADC) like Namibia, Botswana, Zimbabwe, and Mozambique.

Why This Matters for the SA Trade Desk

From a trade perspective, this initiative is an opportunity to leapfrog traditional industrial limitations. Participating in these heavily funded Research & Innovation Actions (RIAs) allows African institutions to secure intellectual property, upgrade local laboratory capacities, and establish early-stage trade and technology relationships with European buyers and industrial clusters.

By integrating African biodiversity expertise with European bio-manufacturing infrastructure, local innovators can ensure that the sustainable, bio-based products of tomorrow are co-authored by African minds.

How to Engage

The clock is ticking for local research offices, science councils, and biotech start-ups to identify European counterparties and draft proposals. Applications must be finalised and submitted before the hard deadline on 17 September 2026.

Find out more information here.

Leave a Reply

Your email address will not be published. Required fields are marked *

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.